Informations générales (source: ClinicalTrials.gov)
The French Registry on the First-line Treatment of Non High-risk Acute Promyelocytic Leukemia (APL) in Patients Aged ≤ 70 Years
Observational [Patient Registry]
Groupe Francophone des Myelodysplasies (Voir sur ClinicalTrials)
octobre 2015
octobre 2022
29 juin 2024
The registry aims to compare the two first-line available treatment approaches in
non-high-risk APL patients aged ≤ 70 years - ATRA plus chemotherapy and ATRA plus ATO -
in terms of practitioner's choice between the two options, clinical effectiveness and
cost-effectiveness, long-term outcome, and short- and long-term toxic effects.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| AP-HP - Hôpital Armand Trousseau-La Roche Guyon | Jean DONADIEU, MD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Henri Mondor-Albert Chenevier | Florence BECKERICH, MD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Necker-Enfants Malades | Ambroise MARCAIS, MD | Contact (sur clinicalTrials) | |||
| CH VICTOR DUPOUY ARGENTEUIL | Ahmad ALJIJAKLI, MD | Contact (sur clinicalTrials) | |||
| CH DE VERSAILLES SITE ANDRE MIGNOT | Anne-Laure TAKSIN, MD | Contact (sur clinicalTrials) | |||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Henri Becquerel - 76038 - Rouen - France | Aspasia STAMATOULLAS, MD | Contact (sur clinicalTrials) | |||
| CH Dr Schaffner - 62307 - Lens - France | Brigitte DUPRIEZ, MD | Contact (sur clinicalTrials) | |||
| CHR Metz-Thionville - Hôpital de Marcy - 57085 - Metz - France | Houria DEBARRI, MD | Contact (sur clinicalTrials) | |||
| Chru - Hopital Claude Huriez - 59037 - Lille - France | Céline BERTHON, MD | Contact (sur clinicalTrials) | |||
| CHU Bordeaux Pellegrin enfant - 33076 - Bordeaux - France | Charlotte JUBERT, MD | Contact (sur clinicalTrials) | |||
| CHU Estaing - 63100 - Clermont-Ferrand - France | Victoria CACHEUX, MD | Contact (sur clinicalTrials) | |||
| CHU Hôpital Sud - service Hémato-oncologie Pédiatrique - 35203 - Rennes - France | Virginie GANDEMER, MD | Contact (sur clinicalTrials) | |||
| CHU Hôtel Dieu - 44035 - Nantes - France | Pierre PETERLIN, MD | Contact (sur clinicalTrials) | |||
| CHU Saint Eloi - 34095 - Montpellier - France | Yosr HICHERI, MD | Contact (sur clinicalTrials) | |||
| Groupe Hospitalier SUD - 80054 - Amiens - France | Delphine LEBON, MD | Contact (sur clinicalTrials) | |||
| Hôpital de la Source - 45100 - Orléans - France | Diana CARP, MD | Contact (sur clinicalTrials) | |||
| Hôpital Jean Minjoz - 25030 - Besançon - France | Fabrice LAROSA, MD | Contact (sur clinicalTrials) | |||
| Hôpital Robert Debré - 75019 - Paris - France | Benoit BRETHON, MD | Contact (sur clinicalTrials) | |||
| Hôpital universitaire Dupuytren - 87042 - Limoges - France | Marie-Pierre GOURIN, MD | Contact (sur clinicalTrials) | |||
| Hôpital V. Provo - 59056 - Roubaix - France | Isabelle DERVITE, MD | Contact (sur clinicalTrials) | |||
| IUCT Oncopole - 31059 - Toulouse - France | Christian RECHER, MD | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Hospitalier d'Aix en Provence - 13616 - Aix en Provence - France | Sylvie CAILLERES, MD | Contact (sur clinicalTrials) | |||
| CHRU de Brest - Pédiatrie Spécialisée - 29609 - Brest - France | Liana CARAUSU, MD | Contact (sur clinicalTrials) | |||
| CHU de Grenoble - 38043 - Grenoble - France | Martin CARRE, MD | Contact (sur clinicalTrials) | |||
| Chu Timone - 13385 - Marseille - France | Gérard MICHEL, MD | Contact (sur clinicalTrials) | |||
| Institut de Cancerologie de La Loire - 42270 - Saint Priest-en-jarez - France | Emmanuelle TAVERNIER, MD | Contact (sur clinicalTrials) | |||
| Institut Paoli Calmettes - 13273 - Marseille - France | Norbert VEY, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Newly-diagnosed APL (either de novo or therapy-related) based on cytologic criteria
and confirmed by the presence of the t(15;17) translocation and/or by the detection
of the fusion transcript PML/RARα.
- Non-high-risk APL (White Blood Count < 10000/μl at presentation)
- Age ≤ 70 years
- Newly-diagnosed APL (either de novo or therapy-related) based on cytologic criteria
and confirmed by the presence of the t(15;17) translocation and/or by the detection
of the fusion transcript PML/RARα.
- Non-high-risk APL (White Blood Count < 10000/μl at presentation)
- Age ≤ 70 years
- Relapsed APL
- Newly-diagnosed High-risk APL (White Blood Count > 10000/μl at presentation)
- Age > 70 years